Genomic profiling

can be used as a powerful tool to identify novel differences and separate out these subpopulations in a more detailed manner. The early stages of human lymphopoiesis are poorly characterized. Common lymphoid progenitors commit to either the NK-cell or the B/T-cell lineages. Two subsets of CD34+ hematopoietic progenitor cells (HPCs) have been proposed as candidate common lymphoid progenitors: CD45RA+CD38–CD7+ cells from the umbilical cord blood and CD45RAhiLin–CD10+ cells from the BM [39, 40]. In vitro experiments showed that umbilical cord blood derived CD34+CD45RAhiCD7+ HPCs skew toward generating T/NK lineages in vitro, while CD34+CD45RAhiLin–CD10+ BM-derived HPCs predominantly exhibit a B-cell potential [39]. Gene expression profiling by DNA microarrays confirmed that CD34+CD45RAhiCD7+ HPCs selectively express NK and T lineage committed genes while Navitoclax mw retaining expression of genes related to the granulomonocytic lineage, whereas CD34+CD45RAhiLin–CD10+ HPCs exhibit a typical pro-B-cell transcriptional profile and generally lack genes unrelated

to the B-cell lineage [41]. https://www.selleckchem.com/products/CAL-101.html Human NK cells account for a small fraction of total lymphocytes (∼10%) in the peripheral blood and are composed of two different subpopulations: the predominant CD56dimCD16+ mature subset (∼95%) and the much smaller CD56brightCD16– immature subset (∼5%) [29]. CD56dim and CD56bright pNK cells have differential expression patterns for cell receptors, adhesion molecules, cytokines, chemokines, TFs, and cytolytic molecules [29, 42, 43]; three studies to date have characterized these two NK-cell subpopulations using genomic profiling (Table 4). All three studies revealed that, compared with CD56bright pNK cells, CD56dim pNK cells upregulate killer cell Ig-like

receptors (KIRs) (including Kir2dl1 and Kir2d2), cytolytic molecules (including Prf1, Gzma, and Gzmb), and chemokines (including Cxcl8, Mip-1b, and Mip-1b) [42-44]. Additionally, Koopman et al. [43] compared CD56bright dNK cells with CD56bright or CD56dim pNK cells and found that CD56bright pNK cells were more similar to the CD56dim pNK-cell subset than they were to the CD56bright dNK cells. Hanna et al. [42] analyzed ∼20 000 genes among purified CD56brightCD16+, CD56dimCD16–, check and in vitro activated CD16+ pNK cells to find that overexpression of certain tetraspanin family receptors (CD9, CD53, CD81) on activated NK cells might enhance or alter their migration to, and retention in, inflamed tissues. Wendt et al. [44] analyzed ∼33 000 genes in resting CD56bright and CD56dim pNK cells, and verified the observed changes in cytokine and chemokine genes at the protein level using cytometric bead array and protein arrays. While GM-CSF, TARC, and TGF-β3 were exclusively expressed in CD56bright pNK-cell supernatants, CD56dim pNK cells were the main producers of IGF-1 and IGFBP-3. GDNF, IGFBP-1, EGF, and TIMP-2 were detected in both CD56bright and CD56dim pNK subsets [44].